These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3965699)

  • 41. Contractile reactivity of isolated resistance arteries after 4 weeks of treatment with rilmenidine, clonidine or hydralazine in spontaneously hypertensive rats.
    Eerdmans PH; Struyker Boudier HA; De Mey JG
    J Hypertens Suppl; 1991 Dec; 9(6):S348-9. PubMed ID: 1818995
    [No Abstract]   [Full Text] [Related]  

  • 42. Rohypnol ("roofies") control of drug discrimination: effect of coadministered ethanol or flumenazil.
    Schechter MD
    Pharmacol Biochem Behav; 1998 Jan; 59(1):19-25. PubMed ID: 9443531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of nimodipine on brightness discrimination learning test in Wistar Kyoto and spontaneously hypertensive rats.
    Nomura M
    Arzneimittelforschung; 1988 Sep; 38(9):1282-6. PubMed ID: 3223970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naloxone reverses the antinociceptive action of clonidine in spontaneously hypertensive rats.
    Tchakarov L; Abbott FV; Ramirez-Gonzalez MD; Kunos G
    Brain Res; 1985 Feb; 328(1):33-40. PubMed ID: 3971179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction of cimetidine with various antihypertensive agents in the spontaneously hypertensive rat.
    Dadkar NK; Aroskar VA; Gupte RD; Dohadwalla AN
    J Pharm Pharmacol; 1985 May; 37(5):372-4. PubMed ID: 2862255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-endorphin: a common factor in the antihypertensive action of clonidine-type imidazolines in spontaneously hypertensive rats.
    Naranjo JR; Fernandez-Roman M; Urdin MC; Fuentes JA
    Gen Pharmacol; 1985; 16(3):287-90. PubMed ID: 3160633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of a diazepam withdrawal symptom by bicuculline and yohimbine.
    Idemudia SO; Mathis DA; Lal H
    Neuropharmacology; 1987 Dec; 26(12):1739-43. PubMed ID: 3125488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the antihypertensive drugs alpha-methyldopa and hydralazine on the performance of spontaneously hypertensive rats in the elevated plus-maze.
    Rosa WC; Oliveira GM; Nakamura-Palacios EM
    Braz J Med Biol Res; 1994 Jan; 27(1):55-9. PubMed ID: 8173530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive activity of arylidenaminoguanidine derivatives.
    Mamolo MG; Vio L; Fabris B; Fischetti F; Carretta R; Giraldi T
    Farmaco Sci; 1986 Nov; 41(11):873-80. PubMed ID: 3803565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using pharmacokinetics in drug therapy. V: Contributions to developing dosage regimens for antihypertensive drugs.
    Schumacher GE
    Am J Hosp Pharm; 1979 Sep; 36(9):1222-6. PubMed ID: 386789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antihypertensive activity of some 2-aminobenzimidazole and indole derivatives.
    Da Settimo A; Marini AM; Primofiore G; Subissi A
    Farmaco; 1991 Feb; 46(2):357-67. PubMed ID: 1859588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of antihypertensive medication on the control of the cardiovascular system during halothane anaesthesia in rats.
    Kaukinen S; Ylitalo P
    Acta Anaesthesiol Scand; 1978; 22(1):64-75. PubMed ID: 636807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug discrimination: methodology and current problems].
    Watanabe S
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):289-302. PubMed ID: 3914149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behavioral evidence for the role of noradrenaline in putative anxiolytic and sedative effects of benzodiazepines.
    Yang XM; Luo ZP; Zhou JH
    Psychopharmacology (Berl); 1988; 95(2):280-6. PubMed ID: 2901123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral and physiological detection of classically-conditioned blood pressure reduction.
    Spencer DG; Yaden S; Lal H
    Psychopharmacology (Berl); 1988; 95(1):25-8. PubMed ID: 3133697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporal differences in behavioral effect of fenfluramine and norfenfluramine.
    Schechter MD
    Pharmacol Biochem Behav; 1990 Mar; 35(3):527-31. PubMed ID: 2339144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyrotropin releasing hormone and naloxone attenuate the antihypertensive action of central alpha 2-adrenoceptor stimulation through different mechanisms.
    Kunos G; Newman F; Farsang C; Ungar W
    Endocrinology; 1984 Dec; 115(6):2481-3. PubMed ID: 6094160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discriminative stimulus control by the anxiogenic beta-carboline FG 7142: generalization to a physiological stressor.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1988 Jun; 30(2):351-5. PubMed ID: 3174766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral acting maps of hydralazine, clonidine, and alpha-methyldopa in spontaneously hypertensive rats as demonstrated by the 14C-deoxy-D-glucose method.
    Hayashi T; Nakamura K
    Jpn J Pharmacol; 1982 Oct; 32(5):855-65. PubMed ID: 7176220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modification by antihypertensive drugs of amphetamine-induced stereotypy in rats.
    van Dorsser W; Roba J
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):326-8. PubMed ID: 575615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.